mRNA |
AS605240 |
GDSC1000 |
pan-cancer |
AAC |
0.0088 |
0.8 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.008 |
0.8 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0088 |
0.8 |
mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
0.0097 |
0.8 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0097 |
0.8 |
mRNA |
SMER-3 |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
BRD-K19103580 |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0095 |
0.8 |
mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
0.0085 |
0.8 |
mRNA |
Irinotecan |
CCLE |
pan-cancer |
AAC |
0.013 |
0.8 |